Interleukin-12 augments cytolytic activity of peripheral blood mononuclear cells against autologous lung cancer cells in combination with IL-2

Lung Cancer

Volumn 35, Issue 3, 2002, Pages 329-333

  Hiraki, Akio ^a   Kiura, Katsuyuki ^a   Yamane, Hiromichi ^a   Nogami, Naoyuki ^a   Tabata, Masahiro ^a   Takigawa, Nagio ^a   Ueoka, Hiroshi ^a   Tanimoto, Mitsune ^a   Harada, Mine ^a  

^a OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

CTL; IL 12; IL 2; Immunotherapy; Lung cancer

Indexed keywords

INTERLEUKIN 12; INTERLEUKIN 2;

ADULT; AGED; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CASE REPORT; CELL ACTIVITY; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXICITY; FEMALE; HUMAN; HUMAN CELL; IMMUNOTHERAPY; LUNG CANCER; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; SOLID TUMOR;

AGED; CYTOTOXICITY, IMMUNOLOGIC; FEMALE; HUMANS; IMMUNOTHERAPY; INTERLEUKIN-12; INTERLEUKIN-2; K562 CELLS; LEUKOCYTES, MONONUCLEAR; LUNG NEOPLASMS; LYMPHOCYTE ACTIVATION; LYMPHOCYTES, TUMOR-INFILTRATING; MALE; MIDDLE AGED; TUMOR CELLS, CULTURED;

EID: 0036181115     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-5002(01)00424-X     Document Type: Article

References (12)

1. Chemotherapy for advanced non-small-cell lung cancer: How much benefit is enough
2. Interleukin-12: A proinflammatory cytokine with immunoregulatory functions
3. Induction of interferon gamma production by natural killer cell stimulatory factor: Characterization of the responder cells and synergy with other inducers
4. Effects of IL-12 on the generation of cytotoxic activity in human CD8+ T lymphocytes
5. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes
6. Loss of HLA haplotype in lung cancer cell lines: Implications for immunosurveillance of altered HLA class I/II phenotypes in lung cancer
7. Response of human natural killer (NK) cells to NK cell stimulatory factor (NKSF): Cytolytic activity and proliferation of NK cells are differentially regulated by NKSF
8. A comparative study of IL-12 (cytotoxic lymphocyte maturation factor)-, IL-2-, and IL-7-induced effects on immunomagnetically purified CD56+ NK cells
9. Pilot study of subcutaneous recombinant human interleukin 12 in metastatic melanoma
10. Phase I study of subcutaneously administered recombinant human interleukin 12 in patients with advanced renal cell cancer
11. Phase I trial of twice-weekly intravenous interleukin 12 in patients with metastatic renal cell cancer or malignant melanoma: Ability to maintain IFN-gamma induction is associated with clinical response
12. Immunological effects of interleukin 12 administered by bolus intravenous injection to patients with cancer